慢性粒细胞白血病是一种造血干细胞克隆性增殖所致的骨髓增殖性疾病。
Chronic myelocytic leukemia is a clonal proliferation of hematopoietic stem cells caused by myeloproliferative disorders.
骨髓增生异常综合征是一种造血干细胞克隆异常性疾病。
Myelodysplastic syndrome (MDS) is a clonal disorder of the hematopoietic stem cell.
单克隆抗体是许多恶性疾病的有效治疗手段。
Monoclonal antibodies are effective treatments for many malignant diseases.
简称“急淋”急性淋巴细胞白血病为起源于造血系统干细胞的克隆性恶性疾病。
Referred to as "ALL", acute lymphoblastic leukemia for the origin of stem cells in the hematopoietic system of clonal malignant disease.
慢性粒细胞白血病CML是造血干细胞的恶性克隆增生性疾病。
Chronic myelocytic leukemia (CML) is the malignant clone disease which occurs in a haematopoietic stem cell.
前言： 目的：自制凝血酶原片段F1+2单克隆抗体，探讨其在血栓性疾病中的诊断作用。
Objective:To prepare a monoclonal antibody against prothrombin fragment 1+2(F1+2) and study its diagnostic effect in patients with thromboembolism.
多发性骨髓瘤是一种浆细胞恶性增生，单克隆免疫球蛋白合成异常的恶性疾病。
Multiple myeloma is a vicious monoclonal B - cell disease with plasmacyte proliferating slowly.
多发性骨髓瘤（MM）是一种起源于B细胞系并能够产生单克隆免疫球蛋白的恶性增生性疾病。
Multiple myeloma(MM) is a kind of malignant hyperplastic diseases, which is origined from B cell line and can produce monoclonal immunoglobulin.
原发性淀粉样变是一种系统性疾病，特点为免疫球蛋白轻链LC蛋白克隆性产生并分布于各组织。
Primary amyloidosis is a systemic disorder characterized by the clonal production and tissue deposition of immunoglobulin light chain (LC) proteins.
一种在研的人类单克隆抗体取得长时间缓解炎性疾病状况的效果。
One human monoclonal antibody in development has achieved long-lasting remission from inflammatory conditions.
通过局部或透皮给送单克隆或多克隆抗体而刺激被动性免疫反应以达到对感染性疾病的预防和治疗。
Our passive immunity patent portfolio concerns the local or topical administration of monoclonal or polyclonal antibody compositions in the prevention and treatment of infectious disease.
通过局部或透皮给送单克隆或多克隆抗体而刺激被动性免疫反应以达到对感染性疾病的预防和治疗。
Our passive immunity patent portfolio concerns the local or topical administration of monoclonal or polyclonal antibody compositions in the prevention and treatment of infectious disease.
应用推荐